| Bioactivity | Succinamic acid is a weak inhibitor for human LL-xylose reductase with an IC50 of 1.45 mM. Succinamic acid can be used as a linker for synthesis of CQ-16 (HY-169336)[1][2]. | ||||||
| CAS | 638-32-4 | ||||||
| Formula | C4H7NO3 | ||||||
| Molar Mass | 117.10 | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Store at room temperature 3 years
|
||||||
| Reference | [1]. Carbone V, et al., Structure-based discovery of human L-xylulose reductase inhibitors from database screening and molecular docking. Bioorg Med Chem. 2005 Jan 17;13(2):301-12. [2]. Chen Q, et al., A Prostate-Specific Membrane Antigen-Targeting Small Molecule-Drug Conjugate Strategy to Overcome the Hematological Toxicity of Olaparib. J Med Chem. 2024 Nov 14;67(21):19586-19611. |
Succinamic acid
CAS: 638-32-4 F: C4H7NO3 W: 117.10
Succinamic acid is a weak inhibitor for human LL-xylose reductase with an IC50 of 1.45 mM. Succinamic acid can be used a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.